ArticleOncoTargets and therapy2023

Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer.

Revathi Badiginchala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.